T. Beissbarth
Molecular Biology · 2004–2012
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 27 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 22 citations into it; #1,346 of 17,773 by trust here, #7,747 by citations
Whom T. Beissbarth trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Beissbarth overall
- Purvesh Khatri
- Tala Bakheet
- Thomas Breslin
- Michael Freeling
- Jelle J. Goeman
- Qi Zheng
- Leif Väremo
- R. Keira Curtis
- Martin C. Frith
- Christina Backes
Papers from T. Beissbarth's perspective
Ordered by how strongly the researchers T. Beissbarth trusts endorse each paper. Same corpus, a different order for every researcher.
- Multiple Hypothesis Testing
- DAVID: Database for Annotation, Visualization, and Integrated Discovery (Genome Biology)
- FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes (Bioinform.)
- A pancreatic islet-specific microRNA regulates insulin secretion (Nature)
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells (Nature Cell Biology)
- Real-time PCR quantification of precursor and mature microRNA. (Methods)
- How microRNAs control cell division, differentiation and death. (Current Opinion in Genetics and Development)
- Preoperative versus postoperative chemoradiotherapy for rectal cancer. (New England Journal of Medicine)
- Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma (British Journal of Haematology)
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening (Gut)
Their papers
- GOstat: find statistically overrepresented Gene Ontologies within a group of genes. (2004) — 1,315 citations
- Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. (2012) — 1,882 citations
- Circulating miRNAs are correlated with tumor progression in prostate cancer (2011) — 603 citations